Alt Text
Office of Neuroscience Research > Bulletin Board > Funding News: NIH Program Announcements > R21 Program Announcement: Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (STANDARD DATES APPLY)

R21 Program Announcement: Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (STANDARD DATES APPLY)

R21 Program Announcement: Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (STANDARD DATES APPLY)
11/20/2009 4:21:55 PM
ONR Administration

PA-10-023
National Institute of Mental Health
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
National Institute on Drug Abuse
Application Receipt/Submission Date(s): Multiple dates, see announcement.
http://grants.nih.gov/grants/guide/pa-files/PA-10-023.html



Return to Postings